Molecular Diagnostics

News on lab-developed tests and emerging diagnostic technologies.

British Startup Biofidelity Eyes Targeted Therapy Space With Novel Reagents

Premium

The team anticipates launching its first clinical diagnostic assay, which will detect targeted, low-frequency genetic mutations in lung cancer, in 2021.

Novacyt Inks French Distribution Deal for Primerdesign Animal Health Testing Products

The deal covers distribution of certain of Primerdesign's molecular testing products to the aquaculture and aquamarine markets in France.

JP Morgan Healthcare Day 3: Exact Sciences, NanoString, Natera, Horizon, Accelerate Dx, GenMark, More

Exact Sciences CEO Kevin Conroy discussed the firm's pipeline and plans for 2020 and beyond, while NanoString CEO Brad Gray talked about the company's GeoMx digital spatial profiling technology, among other presentations Wednesday.

GenDx Gets CE Mark for HLA Typing Products

The firm also has an early-access program for a new amplification strategy that combines 11 HLA genes for typing.

Color Raises $75M to Scale Infrastructure

The financing round comes as Color expands its partnerships with healthcare systems and builds out a national genetic counseling resource for NIH's All of Us program.

Jan 15, 2020

Roche Gets CE Mark for Adenovirus Transplant Monitoring Test

Jan 15, 2020

JP Morgan Healthcare Day 2: 10x Genomics, GenapSys, Caris, Adaptive Bio, Danaher, Agilent, Luminex

Jan 14, 2020

Illumina, Genomics England Ink Deal to Sequence up to 300K People

Jan 14, 2020

BioMérieux Submits 43-Target BCID2 Test to FDA

Jan 14, 2020

Genomic Testing Cooperative, C2i Collaborate on Liquid Biopsy Tests for Solid Tumors

Jan 14, 2020

Qiagen, Amgen Collaborate to Develop CDx for Investigational NSCLC Drug

Jan 13, 2020

JP Morgan Healthcare Day One: Qiagen, Guardant Health, Bio-Rad, Hologic, Myriad Genetics

Jan 13, 2020

MGI Receives CE Mark, Regulatory Clearance in Asia-Pacific Countries for Several Sequencers

Jan 13, 2020

Roche, Illumina Partner on Next-Generation Sequencing IVD, CDx Development, Marketing

Jan 13, 2020

SpeeDx, LabCorp Will Codevelop MDx Tests

Jan 13, 2020

Lab Genomics to Distribute Contextual Genomics' Liquid Biopsy Assay

Jan 13, 2020

Natera Sues CareDx Over New Cell-Free DNA Patent

Jan 13, 2020

Guardant Health to Develop Liquid Biopsy CDx for Amgen KRAS G12C Inhibitor

Jan 13, 2020

CareDx Preliminary Q4 Revenues up 53 Percent

Jan 13, 2020

Adaptive Biotechnologies, Genentech Partner on MRD Testing in Venetoclax Clinical Trial

Jan 13, 2020

HTG Molecular Expects 11 Percent Drop in 2019 Revenues

Jan 13, 2020

Interpace Biosciences to Sell $20M in Preferred Stock, Plans Reverse Stock Split

Jan 13, 2020

GenMark Reports Preliminary Q4 Revenues up 40 Percent

Jan 12, 2020

Exact Sciences Preliminary Q4 Revenues Beat Estimates

Jan 12, 2020

Hologic Preliminary Fiscal Q1 Revenues Rise 2 Percent

Breaking News

The Scan

Hundreds and Hundreds Retracted

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

Guilty Plea in Kickback Case

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

Florida Bill Moves Ahead

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

Science Presents Studies Into Disease-Causing Mutations Among Bone Marrow Donors; Links Between Heavy Drinking, Other Disease

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.

Featured White Papers

Explore the Complexity of the Nervous System: an eBook

BCR-ABL1 Monitoring on the IS Using a Clinically and Analytically Validated Multiplex Assay Directly Aligned to the WHO Primary Standards that Unifies Reporting Formats

Unifying QuantideX NGS DNA and RNA Panels: Methods for Detecting Cancer Hotspots, SNVs, INDELs and Gene Fusions on a Single Flow Cell

Genetic Testing as a Tool for Improving Care and Outcomes for Patients with Rare Inherited Retinal Diseases

Jan

28

Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb

05

Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb

20

Featured Webinar

Advances in NGS Gene Expression Studies to Reduce The Cost of Sequencing

This webinar will discuss the use of 3’ mRNA sequencing to reduce the cost of gene expression studies on Illumina NGS systems.

Feb

26

Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

Menu

Molecular Diagnostics

What's Popular?

Sponsorships